Reprieve Cardiovascular
Company Details
Status: Private
Employees: 11-50
Location:
Milford, Massachusetts, United States
Type:
sample
sample
sample
Technology:
sample
sample
About: Reprieve Cardiovascular, Inc. is developing innovative and groundbreaking therapies that aim to improve the lives of more than 25 million heart failure patients around the world. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for heart failure patients. In 2022, Reprieve initiated the FASTR Trial (pilot study) to compare decongestive therapy administered by the Reprieve Decongestion Management System to Optimal Diuretic Therapy in the treatment of patients diagnosed with acute decompensated heart failure.
Reprieve is a privately held medical device company, headquartered in Milford, Massachusetts, USA.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Reprieve Cardiovascular | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.